Business Services Industry
Banyu Pharmaceutical Confirms Efficacy of Propecia in Long-term
JCNN News Summaries - Japan Corporate News Network, May 30, 2006 by Aki Tsukioka
Tokyo, May 30, 2006 - (JCN) - On May 29, Banyu Pharmaceutical announced that the results of its recent trial of Propecia, an agent for the treatment of androgenetic alopecia (AGA), have been published in the May 16 issue of Japanese Journal of Clinical Dermatology, an academic dermatology journal.
According to the journal, the company has confirmed the safety and efficacy of Propecia Tablet 1mg in a 3-year administration. Propecia (finasteride), which was developed by Merck & Co., is indicated for the treatment of male pattern hair loss on the vertex and anterior mid-scalp area.
c 2006 Japan Corporate News Network. All rights reserved.
Provided by ProQuest Information and Learning Company. All rights Reserved.
Most Recent Business Articles
- How do I determine my retainer fee?
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- The CLNC® mentors held the key to my first case and to my CLNC® success
- Atlanta CLNC® 6-day certification seminar photo gallery—plus sign up today for spring 2009 to save $100.00
- Speak to a full-time practicing CLNC® consultant
Most Recent Business Publications
Most Popular Business Articles
- Using object-oriented analysis and design over traditional structured analysis and design
- Big Fish Games Migrates Upstream to Fisher Plaza; High Growth Online Gaming Firm Vaults Fisher Plaza Occupancy Rate Above 90%
- Top of the line: some of the world's most well-respected doctors practice in South Florida. A guide to choosing the best physician specialists - Top Doctors in South Florida
- Sand filter basics: high-rate sand filters can be confusing for those new to the business. Understanding valve modes is the key
- BEHR Paints Introduces a Colorful New Way to Paint and Prime All in One with BEHR Premium Plus Ultra™ Interior
Most Popular Business Publications
Content provided in partnership with http://findarticles.com/source//
Sponsored by Merrill Lynch